Suggestions
Alina Charter
Global Director, Market Access, Pricing, HEOR and RWE
Dr. Alina Charter is a pharmaceutical executive with expertise in market access, commercial operations, and rare disease policy.46 She currently serves as the Vice President of Market Access and Policy at Alnylam Pharmaceuticals.2 Dr. Charter has extensive experience in the pharmaceutical industry, with expertise across over 20 therapeutic areas in oncology and pharma.4
Career Highlights
- Current Role: Vice President, Market Access and Policy at Alnylam Pharmaceuticals2
- Previous Experience: Senior Health Economics and Market Access Manager at AstraZeneca Canada1
- Leadership: Leads teams and drives innovative market access strategies4
- Recruitment: Involved in recruiting for executive-level positions in the pharmaceutical industry3
Expertise and Interests
- Specializes in rare disease policy and advocates for holistic care approaches6
- Champions patients' access to treatments5
- Focuses on innovative market access strategies and early access programs3
Education and Location
- Holds a DVM (Doctor of Veterinary Medicine) and MSc degree1
- Education includes studies at SDA Bocconi4
- Based in Basel, Switzerland4
Dr. Charter is active on LinkedIn, frequently sharing insights on pharmaceutical industry trends, rare disease policy, and market access strategies.567